ATS 2024 Final Program

Click on the session title to view the speakers

316

WEDNESDAY • MAY 22

Objectives At the conclusion of this session, the participant will be able to: • describe the benefits of multidisciplinary approaches to lung cancer screening across the continuum, including identifying eligible individuals, implementing high-quality screening, and tracking LCS patients for optimizing annual adherence • define best practices for engaging interdisciplinary collaborators within an institution to promote high-quality lung cancer screening. • apply team-based approaches to reduce health inequities in early detection of lung cancer. The proposed session focuses on the multidisciplinary approach to lung cancer screening (LCS) and includes speakers from critical subspecialty partners for Pulmonary Medicine including Thoracic Surgery, Thoracic Radiology, Primary Care, Population , and Cancer Epidemiology. Topics will cover the continuum of lung cancer early detection, from defining lung cancer risk and engaging primary care physicians to managing LCS results and improving screening equity, with an emphasis on interdisciplinary cooperation and engagement. 8:15 Patient Speaker 8:20 Defining population-based lung cancer risk at national and local levels 8:37 Engaging primary care providers for identification of LCS-eligible individuals 8:54 Leveraging the electronic medical record for reporting and tracking LCS results 9:11 Programmatic approaches for building effective interdisciplinary LCS teams 9:28 Improving health equity in LCS at a safety-net hospital This session and the International Conference are supported by an independent medical educational grant from Merck&Co., Inc. All CMEsessions have been planned and implemented in accordancewith the AccreditationCriteria of theAccreditationCouncil for ContinuingMedical Education (ACCME ® ) and are free of the control of ineligible companies (formerly commercial interests).

BASIC • TRANSLATIONAL MINI SYMPOSIUM

D12 POUR SOME SUGAR ON ME:

METABOLISM IN LUNG INJURY AND REPAIR

8:15 a.m. - 10:15 a.m.

San Diego Convention Center Room 2 (Upper Level)

Oral Presentations: 8:15 Metabolic Regulation of Disease Tolerance by Itaconate: Implications for Pseudomonas Aeruginosa Infection and Cystic Fibrosis 8:27 Glycolytic Reprogramming of Alveolar 8:39 Scap Deficiency in Macrophage Alleviates Aspergillus Fumigatus Induced Allergic Lung Inflammation Via Glucose Metabolism 8:51 Metabolic Oscillators Guide Time of Day Variation in Myeloid Cell Inflammatory Responses 9:03 TRPV4 Regulates the Macrophage Metabolic Response Through GLUT1 to Limit Sepsis-induced Lung Injury 9:15 Porphyromonas Gingivalis Mediated T17 Cell Polarization Promotes Lung Cancer Resistance to Immunotherapy 9:27 Gut Microbiome Lipid Biosynthesis Is Associated With Allergic Respiratory Phenotypes and Inflammatory Nasal Transcriptome in Urban Children With Asthma 9:39 Live Microbes in Gut Microbiome Transplant From Pups Prenatally Exposed to Environmental Particles Are Required for the Pro-Asthma Effect on the Epigenome of Recipients’ Dendritic Cells 9:51 Acute Fungal Allergen (Alternaria Alternata) Exposure Shows Time-of-Day Response and Sex-based Difference in Allergic Asthma 10:03 Metformin Protects Alveolar Epithelial Cell Type-2 From Cigarette Smoke-Induced Metabolic Dysfunction Macrophages Contributes to Reduced Vesicular Socs3 Secretion in Tumor-bearing Lungs

ATS 2024 • San Diego, CA